This double-blind drug study enrolls patients currently hospitalized with acute heart failure who will be randomized to Dapagliflozin or placebo treatment arms.

The Reflection study enrolled Veterans who opted to be screened with Galleri, a multi-cancer early detection blood test which can detect the presence of 50+ cancers at time of blood draw.